Isopropamide
|
WikiDoc Resources for Isopropamide |
|
Articles |
|---|
|
Most recent articles on Isopropamide Most cited articles on Isopropamide |
|
Media |
|
Powerpoint slides on Isopropamide |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Isopropamide at Clinical Trials.gov Clinical Trials on Isopropamide at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Isopropamide
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Isopropamide Discussion groups on Isopropamide Patient Handouts on Isopropamide Directions to Hospitals Treating Isopropamide Risk calculators and risk factors for Isopropamide
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Isopropamide |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Isopropamide is a long-acting anticholinergic drug. It is used in the treatment of peptic ulcers and other gastrointestinal disorders involving hyperacidity (gastrointestinal acidosis) and hypermotility. Chemically, it contains a quaternary ammonium group. It is most often provided as an iodide salt, but is also available as a bromide or chloride salt. It was discovered at Janssen Pharmaceutica in 1954.
